MV Credit supports Ephios Luxembourg's acquisition offer for SYNLAB AG, a leading European clinical laboratory and diagnostic services provider.
Information on the Target
SYNLAB AG is recognized as one of Europe’s foremost providers of clinical laboratory and medical diagnostic services. The company specializes in delivering a wide range of laboratory analyses and diagnostics to healthcare providers, ensuring high standards of quality and reliability. As a leader in its field, SYNLAB operates across various countries, enhancing its market presence and service capabilities.
With a strong commitment to innovation and technology, SYNLAB continuously invests in advanced diagnostic tools and methods. This approach not only enhances patient care but also supports healthcare providers in delivering timely and accurate medical diagnoses.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The clinical laboratory and medical diagnostics industry in Europe is experiencing significant growth driven by several factors, including an aging population, increasing prevalence of chron
Similar Deals
Varian Medical Systems, Inc. → MeVis Medical Solutions AG
2015
Ephios Luxembourg S.a.r.l.
invested in
SYNLAB AG
in 2023
in a Public-to-Private (P2P) deal